Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Liberman, 2007, Glucocorticoids in the regulation of transcription factors that control cytokine synthesis, Cytokine Growth Factor Rev, 18, 45, 10.1016/j.cytogfr.2007.01.005
Petta, 2016, The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases, Microbiol Mol Biol Rev, 80, 495, 10.1128/MMBR.00064-15
Ratman, 2013, How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering, Mol Cell Endocrinol, 380, 41, 10.1016/j.mce.2012.12.014
Refojo, 2001, Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids, Immunol Cell Biol, 79, 385, 10.1046/j.1440-1711.2001.01023.x
Stahn, 2008, Genomic and nongenomic effects of glucocorticoids, Nat Clin Pract Rheumatol, 4, 525, 10.1038/ncprheum0898
Busillo, 2013, The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore, Trends Endocrinol Metab, 24, 109, 10.1016/j.tem.2012.11.005
D’Mello, 2009, Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation, J Neurosci, 29, 2089, 10.1523/JNEUROSCI.3567-08.2009
Konsman, 2002, Cytokine-induced sickness behaviour: mechanisms and implications, Trends Neurosci, 25, 154, 10.1016/S0166-2236(00)02088-9
Plotkin, 1996, Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier, J Neuroimmunol, 67, 41, 10.1016/S0165-5728(96)00036-7
Rivest, 2000, How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli, Proc Soc Exp Biol Med, 223, 22, 10.1111/j.1525-1373.2000.22304.x
Watkins, 1995, Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication, Neurosci Lett, 183, 27, 10.1016/0304-3940(94)11105-R
Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther, 130, 226, 10.1016/j.pharmthera.2011.01.014
Pereda, 2000, Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas, Exp Clin Endocrinol Diabetes, 108, 202, 10.1055/s-2000-7887
Turrin, 2004, Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems, Exp Biol Med (Maywood), 229, 996, 10.1177/153537020422901003
Cruz-Topete, 2015, One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids, Neuroimmunomodulation, 22, 20, 10.1159/000362724
Howell, 2006, Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice, Front Neuroendocrinol, 27, 275, 10.1016/j.yfrne.2006.05.001
Kleiman, 2007, Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice, Mol Cell Endocrinol, 275, 98, 10.1016/j.mce.2007.05.009
Barnes, 2009, Glucocorticoid resistance in inflammatory diseases, Lancet, 373, 1905, 10.1016/S0140-6736(09)60326-3
Bertini, 1988, Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor, J Exp Med, 167, 1708, 10.1084/jem.167.5.1708
Edwards, 1991, The pituitary gland is required for protection against lethal effects of Salmonella typhimurium, Proc Natl Acad Sci U S A, 88, 2274, 10.1073/pnas.88.6.2274
MacPhee, 1989, Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids, J Exp Med, 169, 431, 10.1084/jem.169.2.431
Ramachandra, 1992, Neuro-hormonal host defence in endotoxin shock, Brain Behav Immun, 6, 157, 10.1016/0889-1591(92)90015-G
Refojo, 2003, Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells, Ann N Y Acad Sci, 992, 196, 10.1111/j.1749-6632.2003.tb03150.x
Ruzek, 1999, Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection, J Immunol, 162, 3527, 10.4049/jimmunol.162.6.3527
Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939
Kumar, 2005, Gene regulation by the glucocorticoid receptor: structure: function relationship, J Steroid Biochem Mol Biol, 94, 383, 10.1016/j.jsbmb.2004.12.046
Beck, 2009, Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases, Endocr Rev, 30, 830, 10.1210/er.2009-0013
Glass, 1997, Nuclear receptor coactivators, Curr Opin Cell Biol, 9, 222, 10.1016/S0955-0674(97)80066-X
Bledsoe, 2002, Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6
Cain, 2015, Specificity and sensitivity of glucocorticoid signaling in health and disease, Best Pract Res Clin Endocrinol Metab, 29, 545, 10.1016/j.beem.2015.04.007
Oakley, 2011, Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids, J Biol Chem, 286, 3177, 10.1074/jbc.R110.179325
Busillo, 2011, Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome, J Biol Chem, 286, 38703, 10.1074/jbc.M111.275370
Ligr, 2012, Mifepristone inhibits GRbeta coupled prostate cancer cell proliferation, J Urol, 188, 981, 10.1016/j.juro.2012.04.102
Lewis-Tuffin, 2007, Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active, Mol Cell Biol, 27, 2266, 10.1128/MCB.01439-06
Charmandari, 2005, The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes, Mol Endocrinol, 19, 52, 10.1210/me.2004-0112
Oakley, 1999, The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action, J Biol Chem, 274, 27857, 10.1074/jbc.274.39.27857
Sousa, 2000, Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform, J Allergy Clin Immunol, 105, 943, 10.1067/mai.2000.106486
Chikanza, 2002, Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform, Ann N Y Acad Sci, 966, 39, 10.1111/j.1749-6632.2002.tb04200.x
Honda, 2000, Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis, Gastroenterology, 118, 859, 10.1016/S0016-5085(00)70172-7
Piotrowski, 2007, Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus, Folia Histochem Cytobiol, 45, 339
Koga, 2005, Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children, Pediatr Blood Cancer, 45, 121, 10.1002/pbc.20308
Shahidi, 1999, Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia, Biochem Biophys Res Commun, 254, 559, 10.1006/bbrc.1998.9980
Lu, 2007, Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor, Mol Cell Biol, 27, 7143, 10.1128/MCB.00253-07
Cooper, 2009, 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation, J Clin Endocrinol Metab, 94, 4645, 10.1210/jc.2009-1412
Stegk, 2009, Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases, Mol Cell Endocrinol, 301, 104, 10.1016/j.mce.2008.10.030
Zbánková, 2007, 11Beta-hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis, J Gastroenterol Hepatol, 22, 1019, 10.1111/j.1440-1746.2006.04529.x
Liberman, 2014, Modulation of the glucocorticoid receptor activity by post-translational modifications, Nucl Recept Res, 1, 1, 10.11131/2014/101086
Golebiowski, 2009, System-wide changes to SUMO modifications in response to heat shock, Sci Signal, 2, ra24, 10.1126/scisignal.2000282
Holmstrom, 2003, Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy, Proc Natl Acad Sci U S A, 100, 15758, 10.1073/pnas.2136933100
Le Drean, 2002, Potentiation of glucocorticoid receptor transcriptional activity by sumoylation, Endocrinology, 143, 3482, 10.1210/en.2002-220135
Tian, 2002, Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor, Biochem J, 367, 907, 10.1042/bj20021085
Iñiguez-Lluhí, 2000, A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy, Mol Cell Biol, 20, 6040, 10.1128/MCB.20.16.6040-6050.2000
Carbia-Nagashima, 2007, RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia, Cell, 131, 309, 10.1016/j.cell.2007.07.044
Druker, 2013, RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity, Mol Cell Biol, 33, 2116, 10.1128/MCB.01470-12
Paakinaho, 2014, SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor, Nucleic Acids Res, 42, 1575, 10.1093/nar/gkt1033
Davies, 2008, Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function, Mol Endocrinol, 22, 1331, 10.1210/me.2007-0360
Antunica-Noguerol, 2016, The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51, Cell Death Differ, 23, 1579, 10.1038/cdd.2016.44
Kotaja, 2002, The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1, J Biol Chem, 277, 30283, 10.1074/jbc.M204768200
Panse, 2004, A proteome-wide approach identifies sumoylated substrate proteins in yeast, J Biol Chem, 279, 41346, 10.1074/jbc.M407950200
Pountney, 2008, NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture, Acta Neuropathol, 116, 603, 10.1007/s00401-008-0437-4
Zhou, 2004, Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses, J Biol Chem, 279, 32262, 10.1074/jbc.M404173200
Pratt, 2003, Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery, Exp Biol Med (Maywood), 228, 111, 10.1177/153537020322800201
Schülke, 2010, Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors, PLoS One, 5, e11717, 10.1371/journal.pone.0011717
Holownia, 2009, Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy, Eur J Med Res, 14, 108, 10.1186/2047-783X-14-S4-108
Storer, 2011, FKBP51 and FKBP52 in signaling and disease, Trends Endocrinol Metab, 22, 481, 10.1016/j.tem.2011.08.001
Woodruff, 2007, Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids, Proc Natl Acad Sci U S A, 104, 15858, 10.1073/pnas.0707413104
Matsushita, 2010, Enhanced expression of mRNA for FK506-binding protein 5 in bone marrow CD34 positive cells in patients with rheumatoid arthritis, Clin Exp Rheumatol, 28, 87
Baker, 2011, NF-kappaB, inflammation, and metabolic disease, Cell Metab, 13, 11, 10.1016/j.cmet.2010.12.008
Erlejman, 2014, NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity, J Biol Chem, 289, 26263, 10.1074/jbc.M114.582882
Nakamura, 2006, Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients, DNA Res, 13, 169, 10.1093/dnares/dsl006
Park, 2007, Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens, Mol Cell Endocrinol, 278, 7, 10.1016/j.mce.2007.08.002
Binder, 2004, Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment, Nat Genet, 36, 1319, 10.1038/ng1479
Zannas, 2016, Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications, Neuropsychopharmacology, 41, 261, 10.1038/npp.2015.235
Zimmermann, 2011, Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study, Am J Psychiatry, 168, 1107, 10.1176/appi.ajp.2011.10111577
De Bosscher, 2009, Minireview: latest perspectives on antiinflammatory actions of glucocorticoids, Mol Endocrinol, 23, 281, 10.1210/me.2008-0283
Desmet, 2017, Glucocorticoid receptors: finding the middle ground, J Clin Invest, 127, 1136, 10.1172/JCI88886
Surjit, 2011, Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor, Cell, 145, 224, 10.1016/j.cell.2011.03.027
Hudson, 2013, The structural basis of direct glucocorticoid-mediated transrepression, Nat Struct Mol Biol, 20, 53, 10.1038/nsmb.2456
Löwenberg, 2008, Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands, Steroids, 73, 1025, 10.1016/j.steroids.2007.12.002
Boldizsar, 2010, Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells, Immunobiology, 215, 521, 10.1016/j.imbio.2009.10.003
Croxtall, 2000, Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism, Br J Pharmacol, 130, 289, 10.1038/sj.bjp.0703272
Ayroldi, 2012, Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways, FASEB J, 26, 4805, 10.1096/fj.12-216382
Scheinman, 1995, Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors, Mol Cell Biol, 15, 943, 10.1128/MCB.15.2.943
De Bosscher, 2003, The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression, Endocr Rev, 24, 488, 10.1210/er.2002-0006
De Bosscher, 2006, Cross-talk between nuclear receptors and nuclear factor kappaB, Oncogene, 25, 6868, 10.1038/sj.onc.1209935
Pascual, 2006, Nuclear receptors versus inflammation: mechanisms of transrepression, Trends Endocrinol Metab, 17, 321, 10.1016/j.tem.2006.08.005
Jonat, 1990, Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone, Cell, 62, 1189, 10.1016/0092-8674(90)90395-U
Helmberg, 1995, Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor, EMBO J, 14, 452, 10.1002/j.1460-2075.1995.tb07021.x
Auphan, 1995, Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis, Science, 270, 286, 10.1126/science.270.5234.286
Vacca, 1992, Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements, J Exp Med, 175, 637, 10.1084/jem.175.3.637
De Bosscher, 1997, Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation, Proc Natl Acad Sci U S A, 94, 13504, 10.1073/pnas.94.25.13504
Liberman, 2007, The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction, FASEB J, 21, 1177, 10.1096/fj.06-7452com
John, 2008, Interaction of the glucocorticoid receptor with the chromatin landscape, Mol Cell, 29, 611, 10.1016/j.molcel.2008.02.010
John, 2011, Chromatin accessibility pre-determines glucocorticoid receptor binding patterns, Nat Genet, 43, 264, 10.1038/ng.759
De Bosscher, 2010, Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?, Brain Behav Immun, 24, 1035, 10.1016/j.bbi.2010.06.010
De Bosscher, 2010, Targeting inflammation using selective glucocorticoid receptor modulators, Curr Opin Pharmacol, 10, 497, 10.1016/j.coph.2010.04.007
Liberman, 2010, Immunomodulation by glucocorticoids: from basic research to clinical implications, Curr Immunol Rev, 6, 371, 10.2174/1573395511006040371
Barnes, 2011, Glucocorticosteroids: current and future directions, Br J Pharmacol, 163, 29, 10.1111/j.1476-5381.2010.01199.x
Vandevyver, 2012, Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation, J Clin Invest, 122, 2130, 10.1172/JCI60006
Ronchetti, 2015, GILZ as a mediator of the anti-inflammatory effects of glucocorticoids, Front Endocrinol, 6, 170, 10.3389/fendo.2015.00170
De Bosscher, 2008, Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems, Eur J Pharmacol, 583, 290, 10.1016/j.ejphar.2007.11.076
Belvisi, 2001, Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity, J Immunol, 166, 1975, 10.4049/jimmunol.166.3.1975
De Bosscher, 2014, Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-kappaB and AP-1, Cell Mol Life Sci, 71, 143, 10.1007/s00018-013-1367-4
De Bosscher, 2005, A fully dissociated compound of plant origin for inflammatory gene repression, Proc Natl Acad Sci U S A, 102, 15827, 10.1073/pnas.0505554102
Vayssière, 1997, Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo, Mol Endocrinol, 11, 1245, 10.1210/me.11.9.1245
Sugimoto, 2016, Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance, J Immunol Res, 2016, 8239258, 10.1155/2016/8239258
Errasfa, 1989, A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice, Br J Pharmacol, 97, 1051, 10.1111/j.1476-5381.1989.tb12561.x
Buckingham, 2006, Annexin 1, glucocorticoids, and the neuroendocrine-immune interface, Ann N Y Acad Sci, 1088, 396, 10.1196/annals.1366.002
Barczyk, 2010, Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3, Blood, 116, 446, 10.1182/blood-2009-10-247106
Fadok, 1998, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF, J Clin Invest, 101, 890, 10.1172/JCI1112
Liu, 1999, Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes, J Immunol, 162, 3639, 10.4049/jimmunol.162.6.3639
McColl, 2009, Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages, J Immunol, 183, 2167, 10.4049/jimmunol.0803503
Franchimont, 2004, Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies, Ann N Y Acad Sci, 1024, 124, 10.1196/annals.1321.009
Sauer, 1996, Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor, J Clin Endocrinol Metab, 81, 73, 10.1210/jc.81.1.73
Ehrchen, 2007, Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes, Blood, 109, 1265, 10.1182/blood-2006-02-001115
Vallelian, 2010, Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity, Blood, 116, 5347, 10.1182/blood-2010-04-277319
Ayroldi, 2009, Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action, FASEB J, 23, 3649, 10.1096/fj.09-134684
Cohen, 2006, GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response, Blood, 107, 2037, 10.1182/blood-2005-07-2760
Elftman, 2007, Corticosterone impairs dendritic cell maturation and function, Immunology, 122, 279, 10.1111/j.1365-2567.2007.02637.x
Hamdi, 2007, Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper, Blood, 110, 211, 10.1182/blood-2006-10-052506
Hontelez, 2013, DC-SCRIPT regulates glucocorticoid receptor function and expression of its target GILZ in dendritic cells, J Immunol, 190, 3172, 10.4049/jimmunol.1201776
Luther, 2009, Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients, J Immunol, 183, 841, 10.4049/jimmunol.0802046
Rutella, 2004, Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications, Immunol Lett, 94, 11, 10.1016/j.imlet.2004.04.015
Cao, 2013, Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans, Blood, 121, 1553, 10.1182/blood-2012-05-432336
Cronstein, 1992, A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1, Proc Natl Acad Sci U S A, 89, 9991, 10.1073/pnas.89.21.9991
Pitzalis, 1997, Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect, J Immunol, 158, 5007, 10.4049/jimmunol.158.10.5007
Pitzalis, 2002, Regulation of leukocyte-endothelial interactions by glucocorticoids, Ann N Y Acad Sci, 966, 108, 10.1111/j.1749-6632.2002.tb04208.x
Weber, 2004, Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils, J Leukoc Biol, 75, 815, 10.1189/jlb.1003505
Besedovsky, 2014, Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4, FASEB J, 28, 67, 10.1096/fj.13-237958
Fischer, 2013, The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis, Mol Cell Endocrinol, 380, 99, 10.1016/j.mce.2013.04.001
Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6
Bouillet, 1999, Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity, Science, 286, 1735, 10.1126/science.286.5445.1735
Knudson, 1995, Bax-deficient mice with lymphoid hyperplasia and male germ cell death, Science, 270, 96, 10.1126/science.270.5233.96
Villunger, 2003, p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa, Science, 302, 1036, 10.1126/science.1090072
Yin, 1999, Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis, Nature, 400, 886, 10.1038/23730
Purton, 2004, Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death, J Immunol, 173, 3816, 10.4049/jimmunol.173.6.3816
Mosmann, 1989, TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu Rev Immunol, 7, 145, 10.1146/annurev.iy.07.040189.001045
Farrar, 2001, An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3, J Exp Med, 193, 643, 10.1084/jem.193.5.643
Ivanov, 2006, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035
Yang, 2008, T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma, Immunity, 28, 29, 10.1016/j.immuni.2007.11.016
Campbell, 2007, FOXP3 modifies the phenotypic and functional properties of regulatory T cells, Nat Rev Immunol, 7, 305, 10.1038/nri2061
Ramírez, 1996, Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro, J Immunol, 156, 2406, 10.4049/jimmunol.156.7.2406
Franchimont, 2000, Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes, J Immunol, 164, 1768, 10.4049/jimmunol.164.4.1768
Liberman, 2009, Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells, FASEB J, 23, 1558, 10.1096/fj.08-121236
Maneechotesuwan, 2009, Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease, PLoS Med, 6, e1000076, 10.1371/journal.pmed.1000076
Biola, 2000, The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes, FEBS Lett, 487, 229, 10.1016/S0014-5793(00)02297-3
Banuelos, 2017, Immunopathology alters Th17 cell glucocorticoid sensitivity, Allergy, 72, 331, 10.1111/all.13051
Ziolkowska, 2000, High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism, J Immunol, 164, 2832, 10.4049/jimmunol.164.5.2832
Momcilović, 2008, Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells, BMC Immunol, 9, 47, 10.1186/1471-2172-9-47
McKinley, 2008, TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice, J Immunol, 181, 4089, 10.4049/jimmunol.181.6.4089
Ramesh, 2014, Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids, J Exp Med, 211, 89, 10.1084/jem.20130301
Schewitz-Bowers, 2015, Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A, Proc Natl Acad Sci U S A, 112, 4080, 10.1073/pnas.1418316112
Banuelos, 2016, BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis, Allergy, 71, 640, 10.1111/all.12840
Zhao, 2013, Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling, Mucosal Immunol, 6, 335, 10.1038/mi.2012.76
Chen, 2004, Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death, Eur J Immunol, 34, 859, 10.1002/eji.200324506
Chen, 2006, Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE, Eur J Immunol, 36, 2139, 10.1002/eji.200635873
Braitch, 2009, Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis, Acta Neurol Scand, 119, 239, 10.1111/j.1600-0404.2008.01090.x
Engler, 2017, Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy, Proc Natl Acad Sci U S A, 114, E181, 10.1073/pnas.1617115114
Wüst, 2008, Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis, J Immunol, 180, 8434, 10.4049/jimmunol.180.12.8434
Olsen, 2015, Glucocorticoids decrease Treg cell numbers in lungs of allergic mice, Eur J Pharmacol, 747, 52, 10.1016/j.ejphar.2014.11.034
Sorrells, 2009, The stressed CNS: when glucocorticoids aggravate inflammation, Neuron, 64, 33, 10.1016/j.neuron.2009.09.032
Butler, 1989, Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha, J Neuroimmunol, 24, 143, 10.1016/0165-5728(89)90108-2
Goujon, 1995, Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice, Brain Res, 702, 173, 10.1016/0006-8993(95)01041-9
Goujon, 1996, Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide, Brain Res Mol Brain Res, 36, 53, 10.1016/0169-328X(95)00242-K
Masferrer, 1992, Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme, Proc Natl Acad Sci U S A, 89, 3917, 10.1073/pnas.89.9.3917
Drew, 2000, Inhibition of microglial cell activation by cortisol, Brain Res Bull, 52, 391, 10.1016/S0361-9230(00)00275-6
Tanaka, 1997, Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids, Glia, 20, 23, 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.0.CO;2-6
Glezer, 2003, MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS, Neuropharmacology, 45, 1120, 10.1016/S0028-3908(03)00279-X
Blais, 2005, Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli, J Neurochem, 95, 1563, 10.1111/j.1471-4159.2005.03480.x
Blais, 2002, In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain, Endocrinology, 143, 4820, 10.1210/en.2002-220598
Nadeau, 2002, Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14, J Immunol, 169, 3370, 10.4049/jimmunol.169.6.3370
Nadeau, 2003, Glucocorticoids play a fundamental role in protecting the brain during innate immune response, J Neurosci, 23, 5536, 10.1523/JNEUROSCI.23-13-05536.2003
Soulet, 2008, Bone-marrow-derived microglia: myth or reality?, Curr Opin Pharmacol, 8, 508, 10.1016/j.coph.2008.04.002
Carrillo-de Sauvage, 2013, Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation, Cell Death Differ, 20, 1546, 10.1038/cdd.2013.108
Frank, 2010, Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide, Brain Behav Immun, 24, 19, 10.1016/j.bbi.2009.07.008
Johnson, 2002, Prior stressor exposure sensitizes LPS-induced cytokine production, Brain Behav Immun, 16, 461, 10.1006/brbi.2001.0638
Johnson, 2003, Effects of prior stress on LPS-induced cytokine and sickness responses, Am J Physiol Regul Integr Comp Physiol, 284, R422, 10.1152/ajpregu.00230.2002
Hermoso, 2004, Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression, Mol Cell Biol, 24, 4743, 10.1128/MCB.24.11.4743-4756.2004
Munhoz, 2006, Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion, J Neurosci, 26, 3813, 10.1523/JNEUROSCI.4398-05.2006
de Pablos, 2006, Stress increases vulnerability to inflammation in the rat prefrontal cortex, J Neurosci, 26, 5709, 10.1523/JNEUROSCI.0802-06.2006
Espinosa-Oliva, 2011, Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus, Neurobiol Aging, 32, 85, 10.1016/j.neurobiolaging.2009.01.012
Frank, 2012, Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses, Brain Behav Immun, 26, 337, 10.1016/j.bbi.2011.10.005
Frank, 2011, Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse, Brain Behav Immun, 25, S21, 10.1016/j.bbi.2011.01.005
Frank, 2013, Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger, Brain Behav Immun, 33, 1, 10.1016/j.bbi.2013.02.004
Blandino, 2009, Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress, Brain Behav Immun, 23, 958, 10.1016/j.bbi.2009.04.013
Frank, 2007, Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses, Brain Behav Immun, 21, 47, 10.1016/j.bbi.2006.03.005
García-Bueno, 2008, Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats, Endocrinology, 149, 1969, 10.1210/en.2007-0482
Madrigal, 2002, The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress, Neuropsychopharmacology, 26, 155, 10.1016/S0893-133X(01)00292-5
Madrigal, 2003, Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain, Neuropsychopharmacology, 28, 1579, 10.1038/sj.npp.1300187
O’Connor, 2003, Inescapable shock induces resistance to the effects of dexamethasone, Psychoneuroendocrinology, 28, 481, 10.1016/S0306-4530(02)00035-5
Ding, 2010, Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells, J Pharmacol Exp Ther, 335, 693, 10.1124/jpet.110.171975
Lannan, 2012, Proinflammatory actions of glucocorticoids: glucocorticoids and TNFalpha coregulate gene expression in vitro and in vivo, Endocrinology, 153, 3701, 10.1210/en.2012-1020